Lucas Sullivan
@lucasbsullivan.bsky.social
730 followers 540 following 34 posts
Associate Professor @ Fred Hutch Studying metabolic constraints of cancer cell proliferation https://research.fredhutch.org/sullivan/en.html On a mote of dust suspended in a sunbeam
Posts Media Videos Starter Packs
Pinned
lucasbsullivan.bsky.social
Next, our 2nd preprint of the week (!), this one driven by @madelouhart.bsky.social

Previously: Mitochondrial inhibition impairs cell proliferation by constraining aspartate (ASP) availability.

Here: we investigate the kinetics of ASP depletion/ proliferation impairments and...surprises ensue!
biorxivpreprint.bsky.social
Succinate Dehydrogenase loss causes cascading metabolic effects that impair pyrimidine biosynthesis https://www.biorxiv.org/content/10.1101/2025.02.18.638948v1
lucasbsullivan.bsky.social
Check out this great interview with a true rising star in metabolism research (and lab alumni)! 🙌
Reposted by Lucas Sullivan
yasesancak.bsky.social
Our paper on regulation of BCAA catabolism by mitochondrial calcium signaling is out!
Mitochondrial calcium signaling regulates branched-chain amino acid catabolism in fibrolamellar carcinoma | Science Advances www.science.org/doi/10.1126/...
Mitochondrial calcium signaling regulates branched-chain amino acid catabolism in fibrolamellar carcinoma
Mitochondrial Ca2+ signaling regulates branched-chain amino acid catabolism in an adolescent liver cancer.
www.science.org
Reposted by Lucas Sullivan
Reposted by Lucas Sullivan
davidmacphersonlab.bsky.social
Our latest, in Science Advances: In vivo CRISPR screen revealed sgRNAs that switch chemosensitive SCLC PDXs to become resistant.We validated KEAP1 as key hit and found KEAP1 alterations in IMpower133 trial, where active NRF2 links to reduced survival in chemo arm www.science.org/doi/10.1126/... 1/2
Reposted by Lucas Sullivan
jen-crainic.bsky.social
Overjoyed to have the opportunity to present my work orally at the Cancer Metabolism Showcase! Hope to see you there virtually!
harrislab.bsky.social
Less than two weeks until the 2025 Cancer Metabolism Showcase and Workshops!

Speaker lineup now online! Register today!

www.cancermetabolismshowcase.org
9:30 AM - 3 PM EST, May 5th and 6th, 2025
www.cancermetabolismshowcase.org
Reposted by Lucas Sullivan
jen-crainic.bsky.social
Obliteride registeration opens today!!! Join the @lucasbsullivan.bsky.social team and help to CURE CANCER FASTER! See you August 9th at the starting line!! @obliteride.bsky.social #Obliteride #Obliteride2025 secure.fredhutch.org/goto/sulliva...
lucasbsullivan.bsky.social
Hello, can you add me please?
Reposted by Lucas Sullivan
jen-crainic.bsky.social
Poster is printed! Looking forward to going to the Keystone Tumor Metabolism meeting next week in Vancouver. Come talk to me about NRF2, cysteine, and novel metabolite discovery! #KSTumorMetab25 #cancermetabolism #keystonesymposia
Reposted by Lucas Sullivan
Reposted by Lucas Sullivan
cterminiphd.bsky.social
We were delighted to have @king5news.com.web.brid.gy visit us in the Termini Lab to discuss how NIH funding cuts could affect cancer research:

m.youtube.com/watch?v=Szo9...

We NEED indirect costs to provide funding needed complete research studies that will lead to life saving discoveries.
Potential NIH funding cuts could affect local cancer research
YouTube video by KING 5 Seattle
m.youtube.com
lucasbsullivan.bsky.social
Thanks to Madeleine for wanting to stick around post-graduation to figure out “the boomerang” and the rest of the team for support, esp Kristian for quantitative efforts. Thanks to NIGMS and NCI for funding. Also, watch out for Madeleine's next act with @saranowinski.bsky.social!
lucasbsullivan.bsky.social
TLDR – we find that, upon SDH loss, the combined effects of ASP depletion and succinate accumulation profoundly inhibit ATCase. Pyrimidine loss impairs ASP consumption for biosynthesis, causing ASP to accumulate until it outcompetes succinate to restart pyrimidines/biosynthesis once again.
lucasbsullivan.bsky.social
The full paper has plenty more (ASP flux measurements, succinate sufficiency, replication stress), so I invite you to give it a full read. There are also fun phenotypes that epitomize some of the logical pitfalls that we metabolism nerds often warn about (e.g. levels =/= flux).
lucasbsullivan.bsky.social
We found SDH impaired cells can reach >10 mM!

Conclusion: succinate competes with diminished ASP at ATCase, blocking pyrimidine synthesis. To our knowledge the first description of this relationship in cells + revealing another potential regulatory function of succinate.
lucasbsullivan.bsky.social
SDH inhibition is distinct from other mitochondrial impairments due to the accumulation of succinate, which we hypothesized to play a role. First, we decreased succinate production by cotreating with the CI inhibitor rotenone. Result: restoration of pyrimidine synthesis, even with comparable ASP.
Rotenone treatment restores carb-Asp levels in AA5 treated cells (at a time point where Asp levels are near identical).
lucasbsullivan.bsky.social
So, what happens if we restore pyrimidines to these cells?

A complete loss of the ASP rebound and a return to the (very reasonable) phenotype of monotonic ASP depletion.

So, SDH loss causes a disproportionate effect on pyrimidine synthesis by impairing ATCase, but why?
Supplementing AA5 treated cells with uridine (Uri) but not asparagine (Asn) or adenine (Ade) prevents the ASP rebound effect.
lucasbsullivan.bsky.social
We next investigated the biosynthetic fates of aspartate and found:

Aspartyl tRNA charge = OK

Purine nucleotides = OK

ASN = OK - Rebounds with ASP

Pyrimidine nucleotides = Depleted at the first step (ATCase, which makes Carb-ASP) - and stays depleted even with rebounding ASP:
Carbamoyl-Aspartate (carb-ASP) levels are depleted by AA5 treatment at 24 hours and remain depleted at 44 hours, when ASP levels had partially recovered.
lucasbsullivan.bsky.social
When we did the same experiment with the SDH inhibitor AA5, we get a strange result:
ASP declines for ~24 hours until proliferation slows, then..ASP rebounds???

Even stranger:
Proliferation doesn't recover with ASP even though we know ASP supplementation would solve the proliferation defect!
Aspartate levels, measured by the GFP/NucRFP ratio, fall for about 24 hours upon AA5 treatment, then rebound.
lucasbsullivan.bsky.social
Deploying our ASP biosensor, jAspSnFR3, Madeleine & co used live cell imaging to continuously measure ASP levels (GFP) and cell number. In two cases – CI inhibition and GOT1/2 DKO cells, ASP levels crash over 24 hours then cell proliferation decays, leading to a new ~steady state.

Very reasonable.
ASP (measured by GFP) declines proportionally to environmental ASP availability in ASP auxotrophs (GOT1/2 DKO cells)
lucasbsullivan.bsky.social
Next, our 2nd preprint of the week (!), this one driven by @madelouhart.bsky.social

Previously: Mitochondrial inhibition impairs cell proliferation by constraining aspartate (ASP) availability.

Here: we investigate the kinetics of ASP depletion/ proliferation impairments and...surprises ensue!
biorxivpreprint.bsky.social
Succinate Dehydrogenase loss causes cascading metabolic effects that impair pyrimidine biosynthesis https://www.biorxiv.org/content/10.1101/2025.02.18.638948v1